AVX pharma announces initiation of a Phase 2 Clinical Trial of AVX-012 Ophthalmic Solution in Dry Eye Syndrome Blog Post

Avizorex Pharma (AVX Pharma), a clinical stage biopharmaceutical company with offices at Barcelona Science Park and focused on the development of novel therapies for Dry Eye Syndrome, today announced the initiation of a Phase 2 clinical trial, evaluating the safety and efficacy of AVX-012 Ophthalmic Solution in patients with mild-to-moderate Dry Eye Syndrome, based on the concept of modulating corneal nerve activity to stimulate basal lacrimation.

 

Boosting natural detoxification pathways in the body to reduce cellular oxidative stress Blog Post

Promoting innate detoxification mechanisms in the body and discovering which supplements increase the efficacy of those biochemical pathways could be an efficient strategy to reduce the cellular oxidative stress and protect our health, according to an article published in the journal Food Chemistry, by the researchers Rafael Franco, from the Institute of Biomedicine of the University of Barcelona at the Barcelona Science Park and Eva Martínez Pinilla, from the Institute of Neurosciences of Asturias (INEUROPA) and the University of Oviedo.

 

Minoryx successfully completes phase 1 clinical trial for lead candidate MIN-102 Blog Post

Minoryx Therapeutics – a drug development company specialized in the discovery and development of new drugs for orphan diseases, which has R& D laboratories at the Barcelona Science Park– announces that it has successfully completed its phase 1 trial with its lead compound MIN-102 targeting X-linked adrenoleukodystrophy (X-ALD), a life threatening orphan CNS disease with high unmet medical need.

 

CataloniaBio grants the ‘BioSuccess of the Year’ award to STAT-Diagnostica Blog Post

The Catalan Association of Biotechnology Companies (CataloniaBio) has recognized Stat-Diagnostica –founded in 2010 at the Barcelona Science Park by Jordi Carrera and Rafael Bru– with the ‘Biosuccess of the Year’ Award. The prize giving ceremony was held yesterday at the Museu Maritimo of Barcelona under his winter networking event CataloniaBio Gala Dinner, a yearly meeting organised by this business association with the aim of enhancing scientific-business cooperation in Catalonia in the field of life sciences and health.

 

Dr Thomas Högberg to head up Mind the Byte office in Scandinavia Blog Post

Mind the Byte, located at the Barcelona Science Park, continues to reinforce its international presence. To this end, Thomas Högberg is joining the company as Business Development Director Scandinavia and Senior Advisor in order to consolidate computational design services in one of the most important pharmaceutical and biotechnology markets in Europe. He will carry out these responsibilities from the company’s offices at the Copenhagen Bio Science Park (COBIS).

 

Researchers find a gene that causes Opitz C syndrome in the only patient diagnosed in Catalonia Blog Post

A team led by the professors Daniel Grinberg and Susana Balcells, from the Institute of Biomedicine of the University of Barcelona (IBUB) at the Barcelona Science Park has identified a gene that causes the Opitz C syndrome in the only patient in Catalonia diagnosed with this genetic disease  which, so far, does not offer treatment possibilities, prenatal diagnosis or genetic counseling. This new scientific advance is a first step to discover the genetic bases of this congenital disease, that causes severe disabilities in patients and has been diagnosed in three people in the Iberian Peninsula, and sixty people in the world.  

 

The V International Academic Symposium of IEB analyses the challenges of energy economics Blog Post

Yesterday, February 7, the V International Symposium of the Barcelona Institute of Economics (IEB) of the UB on the challenges in the energy sector took place at he Barcelona Science Park. The previous day, the Foundation for Energy and Environmental Sustainability (Funseam), which analyzes and shares the results of the research of the Chair of Energy Sustainability of the UB, had also organized its V International Symposium at PCB with the participation from public officers and businesspeople from the main firms of this sector. 

 

Salvador Aznar Benitah receives the VI National ‘Doctores Diz Pintado’ Cancer Research Prize Blog Post

ICREA researcher and group leader of the Stem Cells and Cancer Laboratory at IRB Barcelona, Salvador Aznar Benitah, has been awarded the VI National ‘Doctores Diz Pintado’ Cancer Research Prize. Last Saturday, he received the award during the academic session held by the University of Salamanca. The prize acknowledges Salvador Aznar Benitah’s contributions to transferring knowledge from basic to clinical research.

 

Carmen Plasencia receives a 2017 ‘femtalent’ award for her Professional Career Blog Post

Carme Plasencia, CEO and cofounder of biotech Aromics, based at the Barcelona Science Park, has won the femtalent award for her Professional Career. Greenaltech and Seed&Click, also located at PCB, received special mention in the categories of ‘Innovation and Organization” with We talent values,  respectively. The presentation of awards took place last Frisay at the Activa Barcelona Technology Park as part of the 2017 edition of the femtalent fòrum, which brought together over 200 attendees and 10 lecturers from the field of entrepreneurship, finances and social innovation.